Text Messaging Adherence to Stimulant Medication

Summary

Text Messaging Adherence to Stimulant Medication is a clinical trial^[1].

Key Facts

• Text Messaging Adherence to Stimulant Medication is in the country of United States^[2].
• Text Messaging Adherence to Stimulant Medication's instance of is recorded as clinical trial^[3].
• Text Messaging Adherence to Stimulant Medication's start time is recorded as +2014-01-31T00:00:00Z^[4].
• Text Messaging Adherence to Stimulant Medication's end time is recorded as +2016-08-31T00:00:00Z^[5].
• Text Messaging Adherence to Stimulant Medication's sponsor is recorded as Massachusetts General Hospital^[6].
• Text Messaging Adherence to Stimulant Medication's main subject is recorded as child^[7].
• Text Messaging Adherence to Stimulant Medication's number of participants is recorded as {'unit': '1', 'amount': '+35'}^[8].
• Text Messaging Adherence to Stimulant Medication's title is recorded as Text Messaging Adherence to Stimulant Medication^[9].
• Text Messaging Adherence to Stimulant Medication's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+6'}^[10].
• Text Messaging Adherence to Stimulant Medication's ClinicalTrials.gov ID is recorded as NCT01967485^[11].
• Text Messaging Adherence to Stimulant Medication's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+17'}^[12].
• Text Messaging Adherence to Stimulant Medication's research intervention is recorded as stimulant^[13].
• Text Messaging Adherence to Stimulant Medication's research site is recorded as Massachusetts General Hospital^[14].
• Text Messaging Adherence to Stimulant Medication's research subject recruitment status is recorded as completed^[15].
• Text Messaging Adherence to Stimulant Medication's study type is recorded as interventional study^[16].